Dividend income
-
Earnings per share
1.63 $
Price/earnings (P/E)
34.86 $
Capitalization
12.73 billion $
Sector
Healthcare
Shares outstanding
224.09 million
Capitalization
12.73 billion $
Price/earnings (P/E)
34.86 $
Earnings per share
1.63 $
Dividend rate
-
Dividend income
-
Incyte Corporation - American multinational pharmaceutical company. The Companys portfolio of medicines includes compounds at various stages, from preclinical trials to the last stages of trials, as well as drugs already in commercial circulation. The company focuses on the discovery, development, and commercialization of patented cancer therapeutics in the United States and internationally.